T. Mooij

发表

Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?

M. Adank, S. Verhoef, C. V. van Asperen, 2016, Menopause.

Risks of Breast, Ovarian, and Contralateral Breast Cancer for $\textit{BRCA1}$ and $\textit{BRCA2}$ Mutation Carriers

J. Hopper, D. Easton, A. Antoniou, 2017 .

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

W. Chung, R. Eeles, J. Hopper, 2017, JAMA.

Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis

R. Tollenaar, H. Meijers-Heijboer, M. Hooning, 2014, International journal of cancer.

Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

W. Chung, R. Eeles, J. Hopper, 2018, JNCI cancer spectrum.

Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort

F. V. van Leeuwen, C. Lambalk, J. Laven, 2011, Human reproduction.

The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations

J. Hopper, E. John, D. Easton, 2018, JNCI cancer spectrum.

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

W. Chung, J. Benítez, R. Eeles, 2020, Breast Cancer Research.

Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.

F. V. van Leeuwen, C. Burger, T. Mooij, 2013, Human reproduction.

A reduced size of the ovarian follicle pool is associated with an increased risk of a trisomic pregnancy in IVF-treated women.

F. V. van Leeuwen, F. Broekmans, C. Burger, 2010, Human reproduction.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

D. Steinemann, F. Couch, B. Bonanni, 2020, Genetics in Medicine.

Factors associated with dizygotic twinning after IVF treatment with double embryo transfer.

M. Heymans, F. V. van Leeuwen, P. Hompes, 2012, Human reproduction.

Miscarriage risk for IVF pregnancies in poor responders to ovarian hyperstimulation.

C. Lambalk, F. Broekmans, C. Burger, 2010, Reproductive biomedicine online.

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

W. Chung, D. Steinemann, F. Couch, 2019, British Journal of Cancer.

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

Katherine M. Tucker, W. Chung, R. Nussbaum, 2018, Journal of the National Cancer Institute.

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

R. Eeles, J. Hopper, D. Easton, 2021, American journal of obstetrics and gynecology.

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence

V. Zadnik, D. Easton, A. Antoniou, 2022, Journal of Medical Genetics.

Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

J. Hopper, E. John, D. Easton, 2019, Cancer Epidemiology, Biomarkers & Prevention.

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

W. Chung, F. Couch, O. Olopade, 2021, Genetics in Medicine.

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up

M. J. van de Vijver, M. Rookus, M. van Beurden, 2004, British Journal of Cancer.

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study

H. V. van Boven, C. Brekelmans, R. Verheijen, 2007, British Journal of Cancer.

Maternal death related to IVF in the Netherlands 1984-2008.

F. V. van Leeuwen, T. Mooij, D. Braat, 2010, Human reproduction.

Low oocyte yield during IVF treatment and the risk of a trisomic pregnancy.

A. Pinborg, M. Haadsma, T. Mooij, 2017, Reproductive biomedicine online.

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits

E. John, D. Easton, A. Antoniou, 2022, Journal of the National Cancer Institute.

Melanoma risk after ovarian stimulation for in vitro fertilization.

F. V. van Leeuwen, C. Burger, M. Schaapveld, 2015, Human reproduction.

Risk of borderline and invasive ovarian tumors after ovarian stimulation for in vitro fertilization in a large Dutch cohort

H. Klip, C. Burger, T. Mooij, 2008 .

Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: a new hypothesis based on historical in vitro fertilisation treatment data.

M. Hauptmann, J. Twisk, F. V. van Leeuwen, 2015, European journal of cancer.

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

E. John, M. Southey, D. Easton, 2023, Breast Cancer Research.

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

W. Chung, J. Benítez, R. Eeles, 2020, Breast Cancer Research.

Abstract 4276: Oral contraceptive use and breast cancer risk: a cohort study ofBRCA1andBRCA2mutation carriers

J. Hopper, D. Easton, A. Antoniou, 2017 .